SCHEMBL3418395

SCHEMBL3418395

CC(C)(N)C(=O)O.C[C@H](NC1(C)CCCCC1)C(=O)O

nearest known ligand 0.36

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
MME P08473 1/20 0.36
LTA4H P09960 1/20 0.34
RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6037209 0.88 MME (0.43) MMELTA4HRAB9A
SCHEMBL203100 0.88 MME (0.43) MMELTA4HRAB9A
SCHEMBL158231 0.88 MME (0.43) MMELTA4HRAB9A
SCHEMBL436374 0.86 MME (0.44) MMELTA4HRAB9A
SCHEMBL27524619 0.86 MME (0.44) MMELTA4HRAB9A
SCHEMBL200644 0.86 MME (0.44) MMELTA4HRAB9A
SCHEMBL6102241 0.82 MME (0.41) MMELTA4HRAB9A
SCHEMBL6102246 0.82 MME (0.41) MMELTA4HRAB9A
SCHEMBL7848861 0.81 MME (0.39) MMELTA4HRAB9A
SCHEMBL5328399 0.78 RAB9A (0.42) MMELTA4HRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3687561-A1 \"IMMUNOREGULATORY MOLECULES AND USES THEREFOR\ The Australian National University (AU) 2020-08-05 EP disclosed
WO-2019040994-A1 \"IMMUNOREGULATORY MOLECULES AND USES THEREFOR\ THE AUSTRALIAN NATIONAL UNIVERSITY (AU) 2019-03-07 WO disclosed
EP-2922862-A1 COMPLEX-FORMATION-MODULATING AGENTS AND USES THEREFOR Queensland University Of Technology (AU) 2015-09-30 EP disclosed
WO-2014078896-A1 COMPLEX-FORMATION-MODULATING AGENTS AND USES THEREFOR QUEENSLAND UNIVERSITY OF TECHNOLOGY (AU) 2014-05-30 WO disclosed
EP-2726154-A1 PREVENTION AND TREATMENT OF ACUTE INFLAMMATORY CONDITIONS The University of Queensland (AU) 2014-05-07 EP disclosed
EP-2646548-A1 IMPROVED LIGHT-EMITTING MOLECULES Gene Stream Pty Ltd. (AU) 2013-10-09 EP disclosed
WO-2013026105-A1 PEST-CONTROLLING AGENTS ISOLATED FROM SPIDER VENOM AND USES THEREOF THE UNIVERSITY OF QUEENSLAND (AU) 2013-02-28 WO disclosed
WO-2012174591-A1 PREVENTION AND TREATMENT OF ACUTE INFLAMMATORY CONDITIONS THE UNIVERSITY OF QUEENSLAND (AU) 2012-12-27 WO disclosed
WO-2012071631-A1 IMPROVED LIGHT-EMITTING MOLECULES GENE STREAM PTY LTD (AU) 2012-06-07 WO disclosed
EP-2231172-A1 IMMUNOMODULATING COMPOSITIONS AND USES THEREFOR Opal Therapeutics Pty Ltd (AU) 2010-09-29 EP disclosed
WO-2009089568-A1 IMMUNOMODULATING COMPOSITIONS AND USES THEREFOR OPAL THERAPEUTICS PTY LTD (AU) 2009-07-23 WO disclosed
EP-1285004-A4 SYNTHETIC PEPTIDES AND USES THEREFORE UNIV AUSTRALIAN (AU) 2006-03-29 EP disclosed
EP-1078003-A4 PLASMIN INHIBITORS FROM THE AUSTRALIAN BROWN SNAKE $i(PSEUDONAJA TEXTILIS TEXTILIS) UNIV QUEENSLAND (AU) 2004-08-25 EP disclosed
EP-1222255-A4 POLYPEPTIDE FRAGMENTS COMPRISING C-TERMINAL PORTION OF HELICOBACTER CATALASE CSL LTD (AU) 2004-03-31 EP disclosed
EP-1285004-A1 SYNTHETIC PEPTIDES AND USES THEREFORE THE AUSTRALIAN NATIONAL UNIVERSITY (AU) 2003-02-26 EP disclosed
EP-1222255-A1 POLYPEPTIDE FRAGMENTS COMPRISING C-TERMINAL PORTION OF HELICOBACTER CATALASE CSL LIMITED (AU) 2002-07-17 EP disclosed
WO-2001090197-A1 SYNTHETIC PEPTIDES AND USES THEREFORE THE AUSTRALIAN NATIONAL UNIVERSITY (AU) 2001-11-29 WO disclosed
WO-2001029198-A1 POLYPEPTIDE FRAGMENTS COMPRISING C-TERMINAL PORTION OF HELICOBACTER CATALASE CSL LIMITED (AU) 2001-04-26 WO disclosed
EP-1078003-A1 PLASMIN INHIBITORS FROM THE AUSTRALIAN BROWN SNAKE $i(PSEUDONAJA TEXTILIS TEXTILIS) THE UNIVERSITY OF QUEENSLAND (AU) 2001-02-28 EP disclosed
WO-1999058569-A1 PLASMIN INHIBITORS FROM THE AUSTRALIAN BROWN SNAKE $i(PSEUDONAJA TEXTILIS TEXTILIS) THE UNIVERSITY OF QUEENSLAND (AU) 1999-11-18 WO disclosed